These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1101753)

  • 1. Urinary metabolites of halothane in man.
    Cohen EN; Trudell JR; Edmunds HN; Watson E
    Anesthesiology; 1975 Oct; 43(4):392-401. PubMed ID: 1101753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A urinary cysteine-halothane metabolite: validation and measurement in children.
    Wark H; Earl J; Chau DD; Overton J; Cheung HT
    Br J Anaesth; 1990 Apr; 64(4):469-73. PubMed ID: 2334621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, biotransformation, and storage of halothane.
    Holaday DA
    Environ Health Perspect; 1977 Dec; 21():165-9. PubMed ID: 348455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotoxicity of the glutathione and cysteine conjugates of 2-bromo-2-chloro-1,1-difluoroethene.
    Finkelstein MB; Baggs RB; Anders MW
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1248-52. PubMed ID: 1602387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of disulfiram, diethyldithiocarbamate and carbon disulfide on the metabolic formation of trifluoroacetic acid from halothane in the rat.
    Eckes L; Büch HP
    Arzneimittelforschung; 1985; 35(9):1447-51. PubMed ID: 3002400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical isotachophoresis utilizing computer simulation. II. Assessment of optimum separation conditions for urinary trifluoroacetic acid metabolized from anaesthetic halothane.
    Hirokawa T; Takemi H; Kiso Y; Takiyama R; Morio M; Fujii K; Kikuchi H
    J Chromatogr; 1984 Feb; 305(2):429-37. PubMed ID: 6707170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The calcium-binding protein calreticulin is covalently modified in rat liver by a reactive metabolite of the inhalation anesthetic halothane.
    Butler LE; Thomassen D; Martin JL; Martin BM; Kenna JG; Pohl LR
    Chem Res Toxicol; 1992; 5(3):406-10. PubMed ID: 1504264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human hepatocytes express trifluoroacetylated neoantigens after in vitro exposure to halothane.
    Ilyin GP; Rissel M; Malledant Y; Tanguy M; Guillouzo A
    Biochem Pharmacol; 1994 Aug; 48(3):561-7. PubMed ID: 8068043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mimicry of trifluoroacetylated human liver protein adducts by constitutive proteins and immunochemical evidence for its impairment in halothane hepatitis.
    Gut J; Christen U; Huwyler J; Bürgin M; Kenna JG
    Eur J Biochem; 1992 Dec; 210(2):569-76. PubMed ID: 1459138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatotoxicity and halothane metabolism in an animal model with application for human toxicity.
    Cousins MJ; Sharp JH; Gourlay GK; Adams JF; Haynes WD; Whitehead R
    Anaesth Intensive Care; 1979 Feb; 7(1):9-24. PubMed ID: 434454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Trifluoroacetyl-ethanolamine: a proposed urinary metabolite of halothane: validation and measurement in children.
    Wark H; Earl J; Chau D; Overton J
    Anaesth Intensive Care; 1991 Aug; 19(3):378-81. PubMed ID: 1767906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolism of 3-chloro,- 3-bromo- and 3-iodoprpan-1,2-diol in rats and mice.
    Jones AR
    Xenobiotica; 1975 Mar; 5(3):155-65. PubMed ID: 1166663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary and biliary excretion of metabolites of halothane in dogs.
    Sakai T; Yoshida H; Fukui A; Takaori M
    Drug Metab Dispos; 1991; 19(2):419-22. PubMed ID: 1676647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of neutrophils in a mouse model of halothane-induced liver injury.
    You Q; Cheng L; Reilly TP; Wegmann D; Ju C
    Hepatology; 2006 Dec; 44(6):1421-31. PubMed ID: 17133481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guinea-pig model of halothane-associated hepatotoxicity in the absence of enzyme induction and hypoxia.
    Lunam CA; Cousins MJ; Hall PD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):802-9. PubMed ID: 3973829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to induce hepatic pathology in animals sensitized to a halothane metabolite and subsequently challenged with halothane.
    Reves JG; McCracken LE
    Anesth Analg; 1976; 55(2):235-42. PubMed ID: 943984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gas chromatographic mass spectrometric determination of trifluoroacetic acid in biological fluid. Application to halothane metabolism.
    Karashima D; Takahashi S; Shigematsu A; Furukawa T; Kuhara T
    Biomed Mass Spectrom; 1976 Feb; 3(1):41-4. PubMed ID: 4173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An animal model of hepatotoxicity associated with halothane anesthesia.
    Sipes IG; Brown BR
    Anesthesiology; 1976 Dec; 45(6):622-8. PubMed ID: 984478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-ethylthiotrifluoroacetate enhancement of the immune response to halothane in the guinea pig.
    Hastings KL; Schuman S; Brown AP; Thomas C; Gandolfi AJ
    Adv Exp Med Biol; 1991; 283():739-44. PubMed ID: 2069050
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic pathology and skin test reactions to trifluoro-acetylated autologous protein after repeated halothane anaesthesia in the guineapig.
    Reves JG; McCracken LE
    Br J Anaesth; 1976 May; 48(5):419-24. PubMed ID: 1276014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.